Notes on Genetic Variation and Disease Diagnosis from Evan Eichler

In this dialogue, Evan Eichler discusses the evolution of genetic mutation discovery since the sequencing of the first human genome. Here’s a detailed breakdown of key concepts and discussions presented throughout the conversation.

  1. Classes of Human Genetic Variation

Eichler explains that the spectrum of human genetic variation is wide, and that mutations can be categorized into several classes, each with distinct characteristics and implications for health:

a. Single Nucleotide Variations (SNVs)

  • The most abundant class of genetic variation, accounting for approximately 90% of individual genetic differences.

  • Involves a change of a single base pair (e.g., adenine to thymine), which can lead to significant differences in protein function.

  • Generally have minimal effects on health, but specific SNVs can predispose individuals to certain diseases or influence drug response.

    b. Indels (Insertions and Deletions)

  • Changes involving 1 to approximately 50 base pairs.

  • These variations can result in either the gain or loss of sequence, potentially resulting in frameshift mutations that alter the reading frame of genes.

  • Indels can influence gene expression, protein structure, and consequently, overall health.

    c. Structural Variations

  • Events involving 50 base pairs and above, potentially affecting large regions of a chromosome.

  • Includes larger gains or losses, orientation changes, and translocations (where a segment of one chromosome is transferred to another).

  • Impact on Disease: Structural variations can significantly affect gene expression and regulation, playing a notable role in various diseases, including cancer.

    d. Chromosomal Aneuploidy

  • Represents the largest scale of genetic variation and involves entire chromosome counts.

  • Example: Trisomy 21 (Down Syndrome), characterized by the presence of an extra chromosome 21, leads to a range of developmental and health issues.

  • Many chromosomal events are lethal, often resulting in miscarriage or severe developmental disorders, which limits their occurrence in live births.

  1. Current Methodologies for Discovering Genetic Variation

    a. Short Read Sequencing

    • This next-generation sequencing method is widely used in clinical settings due to its cost-effectiveness and speed.

    • It excels in detecting SNVs but struggles with structural variations due to:

      • Mapping bias against recurrent regions, leading to inaccurate representations of complex genomes.

      • Inferences made on structural changes rather than direct sequencing, limiting the understanding of sequence context.

      • Approximately 75% of structural variations are missed by this method due to its reliance on reference genome alignment and short sequence mappings.

    b. Limitations of Current Techniques

    • Short read sequencing does not provide a complete picture of genetic variations and often necessitates follow-up investigations to elucidate complex genetic architecture.

    • Can effectively identify single nucleotide mutations but has difficulty resolving complex structural changes that may have significant health implications.

  2. Advancements and Future of Genetic Discovery Techniques

    a. Long Read Sequencing

    • An emerging technology that uses longer DNA fragments to sequence entire regions of the genome, providing a better context for interpreting structural variations.

    • Advantages include:

      • Ability to map through complex repetitive regions that are often problematic for short reads.

      • Directly captures breakpoints and sequence contents, which is vital for understanding diseases like cancer or congenital disorders.

      • This can enhance the clarity surrounding polymorphisms that contribute to population diversity in diseases.

    b. Clinical Application

    • Limited use currently due to:

      • High costs (around $15,000 to $20,000 per genome, compared to $1,000 for short reads), making it less accessible for routine clinical application.

      • Lower throughput with high error rates, which complicates the validation of results.

      • As technology continues to advance, costs are expected to decrease, which could broaden clinical usage and enhance personal medicine approaches for various disorders.

  3. Challenges and Barriers

    a. Throughput and Time

    • Overcoming low throughput is crucial; short read technologies have been optimized for over a decade, creating a knowledge gap for newer long-read technologies.

    • Development requires extensive R&D before clinical application can become viable and widely accepted.

    b. Need for Custom Reference Genomes

    • Eichler suggests that moving towards samples where each patient's DNA acts as its own reference can enhance genomic assemblies and accuracy.

    • Desiring to see the entire inherited genome (both maternal and paternal) can boost variant discovery, ultimately enhancing our understanding of genetic diseases and individual responses to treatment.

Conclusion

Eichler’s viewpoint highlights a transformative approach in genomic studies, advocating for the establishment of patients’ genomes as unique references rather than relying strictly on standard reference genomes. Customizing genomic analyses based on individual variations could lead to significant advances in our understanding of genetic diseases, improving the accuracy of genetic diagnoses. Dr. Eichler expresses optimism about the trajectory of genetic research and discovery, emphasizing the importance of innovative methodologies to unravel the complexities of human genetics as they continue to evolve.